Remove 2020 Remove Coronary Artery Disease Remove Myocardial Infarction
article thumbnail

Mortality rate of percutaneous coronary interventions in ST-segment elevation myocardial infarction patients under the public health insurance schemes of Thailand

Frontiers in Cardiovascular Medicine

BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.

article thumbnail

Prevalence and effects of acute myocardial infarction on hospital outcomes among COVID-19 patients

Coronary Artery Disease Journal

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. Methods Data from the 2020 California State Inpatient Database was used retrospectively. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients.

article thumbnail

Comorbidities prior to out-of-hospital cardiac arrest and diagnoses at discharge among survivors

Open Heart

Previously, 80% of sudden cardiac arrest have been attributed to coronary artery disease. Survival curves were performed among hospitalised patients with acute myocardial infarction (AMI) as well as heart failure. Coronary artery disease is now likely in the minority with regard to causes of OHCA.

article thumbnail

Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention

Open Heart

Patients with coronary artery disease were excluded. Results From 1 January 2005 to 31 December 2020, 2727/18 988 (14.4%) patients were SMuRF less, with the proportion increasing over time. vs 3.9%, p<0.001) and ST-elevation myocardial infarction (59.1% The primary outcome was 30-day mortality.

article thumbnail

Impact of serum iron levels on in-hospital mortality and clinical outcomes in patients with ST segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention: a retrospective analysis

Coronary Artery Disease Journal

Background Despite advances in percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction (STEMI), in-hospital mortality remains a concern, highlighting the need for the identification of additional risk factors such as serum iron levels. μmol/L) and a control group (Fe ≥7.8 μmol/L). μmol/L).

article thumbnail

The impact of COVID-19 and the COVID-19 pandemic on hospitalized patients with STEMI in the United States: insights from the National Inpatient Sample

Coronary Artery Disease Journal

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. reduction in admissions in 2020. reduction in admissions in 2020. In 2020, 3.0% vs. 10.7%; P < 0.001). compared to 10.7%

article thumbnail

What does the angiogram show? The Echo? The CT coronary angiogram? How do you explain this?

Dr. Smith's ECG Blog

Angiogram No obstructive epicardial coronary artery disease Cannot exclude non-ACS causes of troponin elevation including coronary vasospasm, stress cardiomyopathy, microvascular disease, etc. Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): The Past, Present, and Future Management [Internet].